An Evidence Based Approach
Buch, Englisch, 483 Seiten, Format (B × H): 160 mm x 241 mm, Gewicht: 910 g
ISBN: 978-981-334-496-9
Verlag: Springer Nature Singapore
Zielgruppe
Research
Autoren/Hrsg.
Fachgebiete
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Pharmakologie, Toxikologie
- Technische Wissenschaften Maschinenbau | Werkstoffkunde Technische Mechanik | Werkstoffkunde Materialwissenschaft: Biomaterialien, Nanomaterialien, Kohlenstoff
- Naturwissenschaften Chemie Physikalische Chemie Molekulare Chemische Nanostrukturen
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Pharmazie
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizin, Gesundheitswesen Labormedizin
Weitere Infos & Material
Part 1: Targeted Drug Delivery.- Chapter 1: Fundamentals of Nanocarriers and Drug Targeting.- Chapter 2: Role of lipid Nanocarriers in Lymphatic Targeting: Promises and Safety Considerations.- Part 2: Nano Particulate Drug Delivery Carriers.- Chapter 3: Synthesis, Pharmacokinetics and Toxicity of Nano-Drug Carriers.- Chapter 4: Nanostructured Lipid Carriers (NLCs): A Modern Versatile Drug Delivery Vehicle.- Chapter 5: Nanocapsules.- Chapter 6: Nanodiamonds for Theragnostic: Manufacturing and Biomedical Applications.- Chapter 7: Evaluation of Nanotoxicity using Zebrafish: Preclinical Model.- Part 3: Nano Vesicular Drug Delivery Carriers.- Chapter 8: Niosomes: A Novel Nanometric Vesicular Systems for Drug Delivery.- Chapter 9: Cubosomes: Novel Nanocarriers for Drug Delivery.- Chapter 10: Self-Nanoemulsifying Drug Delivery Systems (SNEDDS): An Innovative Approach To Improve Oral Bioavailability.- Chapter 11: Nanotechnological Approach for Design and Delivery of Phytopharmaceuticals.- Chapter 12: Liposomes: As a Potential Drug Carrier.- Part 4: Nanocarriers in Biotechnology.- Chapter 13: Potential Applications of Cationic Lipids in Nucleic Acid Based Therapeutic Delivery System.- Chapter 14: Nanocarriers in Protein and Peptide Drug Delivery.- Part 5: Nanocarriers in Oral Cancer.- Chapter 15: Nanotechnology in Oral Cancer Treatment.- Part 6: Nanocarriers for Site Specific Delivery.- Chapter 16: Nanocarriers in Transdermal Drug Delivery.- Chapter 17: Leveraging Nanotechnology in Cosmeceuticals: Formulation, Characterization, Regulatory Status and Toxicity.- Chapter 18: Nanotechnology in Ocular Drug Delivery.